Share this post on:

Product Name :
MDNA-57

Search keywords :
IL-13 Receptor alpha 1

drugId :
null

Target Vo:
Interleukin-4 receptor subunit alpha

Target Vo Short Name :
IL4RA

Moa_Name:
Interleukin-4 receptor subunit alpha inhibitors

First Approval Country :

First Approval Date Filter:
null

Origin Company_Name :
Medicenna Therapeutics

Active Company_Name :
Medicenna Therapeutics

Active Indication_Name:
Solid tumours

In Active Indication_Name:

Termination Status :

China Termination Status :

Highest Status:
Preclinical

China Highest Status:

Antibodies are immunoglobulins secreted by effector lymphoid B cells into the bloodstream. Antibodies consist of two light peptide chains and two heavy peptide chains that are linked to each other by disulfide bonds to form a “Y” shaped structure. Both tips of the “Y” structure contain binding sites for a specific antigen. Antibodies are commonly used in medical research, pharmacological research, laboratory research, and health and epidemiological research. They play an important role in hot research areas such as targeted drug development, in vitro diagnostic assays, characterization of signaling pathways, detection of protein expression levels, and identification of candidate biomarkers.
Related websites: https://www.medchemexpress.com/antibodies.html
Popular product recommendations:
Calnexin Antibody (YA573)
E-Cadherin Antibody (YA470)
CXCL5 Antibody: CXCL5 Antibody is an unconjugated, approximately 8/9 kDa, rabbit-derived, anti-CXCL5 polyclonal antibody. CXCL5 Antibody can be used for: ELISA, IHC-P, IHC-F, IF expriments in rat, and predicted: mouse background without labeling.

Share this post on:

Author: Interleukin Related